AlphAIalphai — Financial news for AI agents
fool.comSEP 23 min read$TLRY

Better Cannabis Stock to Buy Right Now: Canopy Growth or Tilray Brands?

Tilray Brands (TLRY) and Canopy Growth (CGC), two major Canadian cannabis retailers, have seen significant stock declines this year. Tilray reported Q4 revenue of $281.7M, up 25% YoY, with cannabis revenue at $71.5M, up 5% YoY. Canopy reported Q1 revenue of CA$81.2M, up 13% YoY. Tilray has lower net debt and is closer to profitability, while Canopy has higher debt and ongoing EBITDA losses.

Original reporting
fool.com
Published Sep 2, 2026, 3:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Sep 2, 2026, 3:40 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
Better Cannabis Stock to Buy Right Now: Canopy Growth or Tilray Brands? — source image
Source · fool.com
Decision brief

The 30-second read

$TLRYBullishLow
01

Why it matters

Both companies posted revenue growth and narrowed losses, but remain unprofitable with high debt levels.

02

Market read

Earnings data may influence short‑term trading decisions in the niche cannabis sector.

03

What to watch

Regulatory environment and potential US market expansion could materially affect future performance.

Relevance 4/10Novelty 2/10Timing: today

Background

The article compares recent earnings results of Tilray Brands and Canopy Growth to suggest a better buy.

Company-level read

Ticker impact

$TLRYBullishMedium confidence
Context

Tilray Brands reported Q4 net revenue of $281.7M, a 25% YoY increase and reduced EPS loss to $0.43.

Expected impact

Potential slight price appreciation if investors value the earnings beat.

Evidence & confidence

Earnings beat and improved margins are new data, but limited scale and ongoing losses temper impact.

$CGCBullishMedium confidence
Context

Canopy Growth posted fiscal 2027 Q1 revenue of CA$81.2M, up 13% YoY, and narrowed EPS loss to CA$0.03.

Expected impact

Possible modest price gain if market rewards the earnings improvement.

Evidence & confidence

Earnings data is fresh but modest in scale; impact likely limited.

Market effects

Sector

Both firms' earnings highlight ongoing challenges in the Canadian cannabis sector.

Regional

Limited impact beyond North American cannabis investors.

Global

Low relevance to broader global markets.

Counterpoint

What could challenge this read

Despite earnings improvements, high debt and lack of profitability may keep shares under pressure.

Key entities

  • company
    Tilray Brands

    Canadian cannabis and consumer goods company.

  • company
    Canopy Growth

    Large Canadian cannabis producer.

Read at source← All news

Related articles

AUG 24
$CURLFHighAI 9/10

Curaleaf's Hostile Takeover Bid for Aurora Is Just the Tip of the Iceberg for Cannabis Consolidation. These 2 Stocks Could Be the Biggest Winners.

Curaleaf has made an unsolicited bid for Aurora Cannabis, offering a 45% premium. Aurora has not accepted the deal. Tilray Brands and Canopy Growth are also engaging in consolidation. Aurora recently acquired Safari Flower, while Canopy bought MTL Cannabis. Tilray is diversifying into alcohol and CBD. Investors should consider risks of consolidation strategies.

aol.com3 min
AUG 23
$TLRYMed

Tilray Posted Record Fiscal 2026 Revenue -- Why Isn't the Stock Rallying?

Tilray Brands reported record fiscal 2026 revenue of $915 million, up 11%, and adjusted EBITDA of $61.1 million, also up 11%. Adjusted net income nearly doubled to $12.2 million, but missed analyst estimates. GAAP net loss was $49.6 million. Management expects fiscal 2027 adjusted EBITDA of $68M-$75M. Cannabis sales represent 29% of total revenue.

yahoo.com3 min
AUG 21
$CURLFHighAI 8/10

Curaleaf's Hostile Takeover Bid for Aurora Is Just the Tip of the Iceberg for Cannabis Consolidation. These 2 Stocks Could Be the Biggest Winners.

Curaleaf (CURLF) has made an unsolicited bid for Aurora Cannabis (ACB), offering a 45% premium. Aurora's response was noncommittal. Canopy Growth (CGC) and Tilray Brands (TLRY) are also consolidating, with Tilray expanding into alcohol and CBD. Investors may benefit from acquisitions, but risks include integration challenges and leverage.

fool.com3 min
AUG 21
$CGCMedAI 8/10

Cannabis Operator CGC Rises 15% in a Month: Time to Buy, Hold or Sell?

Canopy Growth Corporation (CGC) shares rose 15% in a month after reporting Q1 fiscal 2027 earnings that beat estimates, showing revenue growth and improved margins. The company's cannabis business is improving, with increased revenues and narrowing losses. However, cash flow remains a concern, and competition in the cannabis market is stiff. Analysts have slightly improved loss estimates but maintain a 'Hold' rating.

zacks.com3 min